No Data
Biogen Price Target Cut to $225.00/Share From $231.00 by RBC Capital
Live Stock News: Tariffs are so Back While Stocks Climb
Biogen Price Target Cut to $140.00/Share From $165.00 by Wells Fargo
Piper Sandler Remains a Hold on Biogen (BIIB)
Biogen Price Target Lowered to $139 From $156 at BMO Capital
Envisagenics Expands Executive Leadership With the Appointment of Sudhir Rao as Chief Business Officer
72886030 : any thoughts why it is dropping after the earnings?
thoughtful Bat_8163 OP 72886030 : forecast? To be honest, it is really disappointing regarding Leqembi rollout. BIIB has betted huge on it. I was expecting much better quarter over quarter growth
72886030 thoughtful Bat_8163 OP : thanks for sharing. hope all the bad news are priced in now.